The APOE2/2 genotype has recently been suggested to be associated with more severe pathology in primary tauopathies, including progressive supranuclear palsy, corticobasal degeneration, and a mouse model of human tau over-expression14. The gene discussed is MAPT; the disease is progressive supranuclear palsy.